Avita Therapeutics shares owned by Capital Analysts
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Capital Analysts
from 13F filings
Historical chart of Capital Analysts investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Capital Analysts
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.0k | 652 | 3.07 |
| 2025-09-30 | $3.0k | 652 | 4.60 |
| 2025-06-30 | $3.0k | 652 | 4.60 |
| 2025-03-31 | $5.0k | 652 | 7.67 |
| 2024-12-31 | $8.0k | 652 | 12.27 |
| 2024-09-30 | $7.0k | 652 | 10.74 |
| 2024-06-30 | $5.0k | 652 | 7.67 |
| 2024-03-31 | $10k | 652 | 15.34 |
| 2023-12-31 | $9.0k | 652 | 13.80 |
| 2023-09-30 | $10k | 652 | 15.34 |
| 2023-06-30 | $11k | 652 | 16.87 |
| 2023-03-31 | $9.0k | 652 | 13.80 |
| 2022-12-31 | $4.0k | 652 | 6.14 |
| 2022-09-30 | $3.0k | 652 | 4.60 |
| 2022-06-30 | $3.0k | 652 | 4.60 |
| 2022-03-31 | $6.0k | 652 | 9.20 |
| 2021-12-31 | $8.0k | 652 | 12.27 |
| 2021-09-30 | $12k | 652 | 18.40 |
| 2021-06-30 | $13k | 652 | 19.94 |
| 2021-03-31 | $13k | 652 | 19.94 |